FIA
TTPH

FNY Investment Advisers’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

FNY Investment Advisers’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-350
Closed -$7K – 1061
2018
Q4 		$7K Buy
350
+255
+268% +$9.97K ﹤0.01% 527
2018
Q3 		$5K Buy
+95
New +$6.07K ﹤0.01% 629

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FNY Investment Advisers's TTPH Position: Q1 2019 in Review

FNY Investment Advisers sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2019, closing a stake of 350 shares — an estimated $7K sold.

FNY Investment Advisers first reported a position in TTPH in Q3 2018 and held it in 2 quarters. The position peaked at $7K in Q4 2018. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • FNY Investment Advisers reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 350 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019, an estimated $7K.
  • FNY Investment Advisers first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
  • FNY Investment Advisers's Tetraphase Pharmaceuticals, Inc. position peaked at $7K in Q4 2018.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on FNY Investment Advisers's 13F filing for Q1 2019, filed 17 Apr 2019.